Phase IIb study of obeticholic acid in the treatment of portal hypertension in patients with liver cirrhosis

Trial Profile

Phase IIb study of obeticholic acid in the treatment of portal hypertension in patients with liver cirrhosis

Planning
Phase of Trial: Phase II

Latest Information Update: 23 Jan 2014

At a glance

  • Drugs Obeticholic acid (Primary)
  • Indications Portal hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Jan 2014 New trial record
    • 09 Jan 2014 Intercept plans to initiate this trial in the second half of 2014, according to a media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top